https://nl.marketscreener.com/koers/aandeel/SINO-BIOPHARMACEUTICAL-LI-6170858/nieuws/Sino-Biopharmaceutical-Limited-kondigt-de-meest-recente-resultaten-aan-van-de-fase-II-klinische-stud-46158824/?utm_source=telegram&utm_medium=social&utm_campaign=share